Thomas E. Willnow

Corporate Officer/Principal at

Humboldt-Universität zu Berlin

Health Technology

Consumer Services

Commercial Services

Profile

Thomas E.
Willnow was the founder of Recepticon ApS, which was founded in 2001, where he held the title of Director & Co-Chief Scientific Officer from 2009 to 2010.
He currently holds the title of Principal at Humboldt-Universität zu Berlin.
Dr. Willnow has held the title of Principal at AGC Biologics SpA and Roche Diagnostics GmbH in the past.
Dr. Willnow received a doctorate degree from Ludwig-Maximilians-Universität München in 1992 and an undergraduate degree from the same institution.

Thomas E. Willnow active positions

Companies	Position	Start
Humboldt-Universität zu Berlin Humboldt-Universität zu Berlin Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	2009-09-01

All active positions of Thomas E. Willnow

Former positions of Thomas E. Willnow

Companies	Position	End
Recepticon ApS Recepticon ApS Pharmaceuticals: MajorHealth Technology Develops receptor antagonists for prevention of medical induced organ damage	Founder	2010-03-22
MOLMED S.P.A.	Corporate Officer/Principal	-
Roche Diagnostics GmbH Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Develops innovative medicines, treatments and diagnostics	Corporate Officer/Principal	-

See the detail of Thomas E. Willnow's experience

Training of Thomas E. Willnow

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Thomas E. Willnow's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
AGC Biologics SpA AGC Biologics SpA Pharmaceuticals: MajorHealth Technology Provides pharmaceutical development and manufacturing services for protein-based biologics, cells & gene therapies and messenger RNA	Health Technology
Roche Diagnostics GmbH Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Develops innovative medicines, treatments and diagnostics	Commercial Services
Ludwig-Maximilians-Universität München Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Recepticon ApS Recepticon ApS Pharmaceuticals: MajorHealth Technology Develops receptor antagonists for prevention of medical induced organ damage	Health Technology
Humboldt-Universität zu Berlin Humboldt-Universität zu Berlin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services